Published in J Pediatr on June 01, 2007
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67
Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet (2001) 2.91
Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature (1995) 2.16
Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC) J Clin Invest (2000) 1.72
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet (1999) 1.62
Chickenpox in apparently 'immune' hospital workers. Infect Control Hosp Epidemiol (1990) 1.58
Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant (2001) 1.53
Trampoline use as physiotherapy for cystic fibrosis patients. Pediatr Pulmonol (2005) 1.42
Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Mol Cell Biol (2000) 1.39
Congenital permanent diabetes: a different type of diabetes? Acta Paediatr (1996) 1.39
Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency. Nat Genet (1998) 1.38
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Respir Crit Care Med (2000) 1.37
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis (1984) 1.26
Functional association between Arf and RalA in active phospholipase D complex. Proc Natl Acad Sci U S A (1998) 1.24
Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J (2001) 1.19
Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol (2001) 1.15
Colonization and bacteremia related to duration of triple-lumen intravascular catheter placement. Am J Infect Control (1990) 1.15
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J (2005) 1.14
Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrheas. Am J Infect Control (1988) 1.14
Three clusters of Bacillus pseudobacteremia related to a radiometric blood culture analyzer. Infect Control (1984) 1.11
Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor. Mol Cell Biol (1999) 1.10
RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene (1999) 1.09
Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy. Am J Hum Genet (2007) 1.08
Selective activation of protein kinase C isoforms by v-Src. Cell Growth Differ (1995) 1.06
Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer. Pharmacogenomics J (2007) 1.03
Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. Am J Hum Genet (1997) 1.03
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood (2000) 1.03
The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet (1998) 1.01
Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews. Am J Med Genet (1999) 0.99
The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis. Am Rev Respir Dis (1984) 0.98
The tomato dark green mutation is a novel allele of the tomato homolog of the DEETIOLATED1 gene. Theor Appl Genet (2002) 0.98
Further studies on erythrocyte thiamin transport and phosphorylation in seven patients with thiamin-responsive megaloblastic anaemia. J Inherit Metab Dis (1994) 0.97
Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families. J Inherit Metab Dis (2002) 0.95
Skoura - a genetic island for congenital insensitivity to pain and anhidrosis among Moroccan Jews, as determined by a novel mutation in the NTRK1 gene. Clin Genet (2009) 0.95
Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics (1999) 0.94
Glutaric aciduria type I in the Arab and Jewish communities in Israel. Am J Hum Genet (1996) 0.93
Nutritional upregulation of p85alpha expression is an early molecular manifestation of insulin resistance. Diabetologia (2006) 0.93
Thiamine-dependent beriberi in the "thiamine-responsive anemia syndrome". N Engl J Med (1984) 0.92
Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum Genet (1995) 0.92
Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J Clin Invest (1998) 0.92
Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains. Biochem Biophys Res Commun (2000) 0.91
Thiamine pyrophosphate: an essential cofactor for the alpha-oxidation in mammals--implications for thiamine deficiencies? Cell Mol Life Sci (2006) 0.90
Comparison of blood cultures obtained simultaneously by venepuncture and from vascular lines. J Hosp Infect (1986) 0.90
Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. Pediatr Cardiol (2003) 0.90
[Flexible bronchoscopy in the diagnosis of foreign body aspiration]. Harefuah (1995) 0.88
Determination of fructose metabolic pathways in normal and fructose-intolerant children: a 13C NMR study using [U-13C]fructose. Proc Natl Acad Sci U S A (1990) 0.88
Injuries resulting from bicycle collisions. Acad Emerg Med (1995) 0.87
Gastroesophageal reflux during sleep in asthmatic patients. J Pediatr (1983) 0.87
First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency). Pediatr Res (1996) 0.87
Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol. Arterioscler Thromb Vasc Biol (1995) 0.87
The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor. Thyroid (1999) 0.87
Profound biotinidase deficiency caused by a point mutation that creates a downstream cryptic 3' splice acceptor site within an exon of the human biotinidase gene. Hum Mol Genet (1997) 0.86
Pulmonary response to a bronchodilator delivered from three inhalation devices. J Pediatr (1984) 0.86
Mucolipidosis III presenting as a rheumatological disorder. J Rheumatol (1993) 0.85
A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. Am J Respir Crit Care Med (1997) 0.85
The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs. Hum Genet (1990) 0.85
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia. Leukemia (2011) 0.85
The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families. Hum Mutat (2000) 0.84
Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells. J Clin Invest (1994) 0.84
Sleep in Pierre Robin syndrome. Chest (1986) 0.84
A missense mutation (His42Arg) in the T-protein gene from a large Israeli-Arab kindred with nonketotic hyperglycinemia. Hum Genet (1998) 0.84
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial. Cancer Chemother Pharmacol (2001) 0.84
Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler. J Pediatr (1983) 0.84
Characteristic urine organic acid profile in peroxisomal biogenesis disorders. J Inherit Metab Dis (2000) 0.83
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome. Ann Oncol (2008) 0.83
Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients. J Clin Immunol (1989) 0.83
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. Bone Marrow Transplant (2006) 0.83
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer. Breast Cancer Res Treat (2011) 0.83
[A rare case of proctorrhagia. Apropos of a case and review of the literature]. Ann Chir (1993) 0.83
Human liver pathology in peroxisomal diseases: a review including novel data. Biochimie (1993) 0.82
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. Br J Cancer (2002) 0.82
Clinical-biochemical correlation in molecularly characterized patients with Niemann-Pick type C. Genet Med (2001) 0.82
Primary sclerosing cholangitis associated with immunodeficiency. Am J Dis Child (1983) 0.82
Biochemical basis of type IB (E1beta ) mutations in maple syrup urine disease. A prevalent allele in patients from the Druze kindred in Israel. J Biol Chem (2001) 0.81
Identification of new mutations in Israeli patients with X-linked adrenoleukodystrophy. Genet Test (2001) 0.81
Suppressor T-lymphocyte activity in wheezy children with and without treatment by hyposensitization. Clin Allergy (1981) 0.81
Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity. Hum Genet (1998) 0.81
Immunolocalization of a 43 kDa peroxisomal membrane protein in the liver of patients with generalized peroxisomal disorders. Eur J Cell Biol (1995) 0.81
Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol (1997) 0.80
Impact of ligand and protein desolvation on ligand binding to the S1 pocket of thrombin. J Mol Biol (2012) 0.80
Inhibition of de novo synthesis of a jelly layer precursor protein by crustacean hyperglycemic hormone family peptides and posttranscriptional regulation by sinus gland extracts in Penaeus semisulcatus ovaries. Gen Comp Endocrinol (2001) 0.80
Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies. Am J Med Genet (1997) 0.80
Primary hyperoxaluria type 1: improved outcome with timely liver transplantation: a single-center report of 36 children. Transplantation (2001) 0.79
Non-parenteral transmission of cytomegalovirus in a neonatal intensive care unit. Lancet (1981) 0.79
Progressive familial intrahepatic cholestasis among the Arab population in Israel. J Pediatr Gastroenterol Nutr (1997) 0.79
RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts. Biochem Biophys Res Commun (2001) 0.78
Peroxisome mosaicism in the livers of peroxisomal deficiency patients. Hepatology (1995) 0.78
[Anterior strut grafting in kyphosis and kyphoscoliosis (author's transl)]. Rev Chir Orthop Reparatrice Appar Mot (1981) 0.78
Thiamin status of the offspring of diabetic rats. Pediatr Res (1988) 0.77
Role of macrophage glycosaminoglycans in the cellular catabolism of oxidized LDL by macrophages. Arterioscler Thromb Vasc Biol (1998) 0.77
Prolidase deficiency diagnosed by 1H NMR spectroscopy of urine. J Inherit Metab Dis (2001) 0.77
Disinfection of respirator tubing: a comparison of chemical versus hot water machine-assisted processing. J Hosp Infect (1983) 0.77
The contribution of perfusion scintigraphy in the evaluation of children suffering from recurrent localized pneumonia. Eur J Nucl Med (1990) 0.77
Infantile Refsum disease: neonatal cholestatic jaundice presentation of a peroxisomal disorder. J Pediatr Gastroenterol Nutr (1995) 0.76
Activation of gene expression by a non-transforming unmyristylated-SH3-deleted mutant of Src is dependent upon Tyr-527. Biochem Biophys Res Commun (1997) 0.76
Isolation and characterization of the high-density lipoproteins from the hemolymph and ovary of the penaeid shrimp Penaeus semisulcatus (de Haan): apoproteins and lipids. J Exp Zool (1997) 0.76
Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells. Biochem Biophys Res Commun (1998) 0.76